3 ms·
They may still actually have an real innovation (we need more evidence), but I do agree that this is a massive failure for such a valuable company. After the h
by ryporter 11y ago
They may still actually have an real innovation (we need more evidence), but I do agree that this is a massive failure for such a valuable company. After the huge setback that 23AndMe suffered from their run-in with the FDA, every well-funded company under their jurisdiction should be triple-checking everything related to FDA compliance, since it poses such a grave, existential risk.
- deleted 11y ago[deleted]
- a_bonobo 11y agoInterestingly, both 23andMe and Theranos just sat on the documents issued to them by the FDA, see https://news.ycombinator.com/item?id=10462936 https://news.ycombinator.com/item?id=10462936 Do both have the same guy working on FDA-approval?
- adventured 11y agoIt's the Uber aggressive approach - break the rules, try to get big faster than they can slow you down - applied to something directly ruled by a federal bureaucracy. That'll never turn out well. With the FDA you have to play the game the way they want you to or they'll instantly nuke your operation. The Uber approach only works if you're dealing with lots of little bureaucracies.